The results of 60 femorofemoral, 27 axillobifemoral, and 15 axillounifemoral bypasses were analyzed. Considered in this order, the operative mortality rate was zero, 11%, and 13%, respectively; initial hemodynamic failure was 7%, 13%, and 9%, respectively; 5-year overall primary patency rate was 67%, 62%, and 19%, respectively; and the secondary patency rate was 74%, 82%, and 37%, respectively. However, axillobifemoral patency was made to seem better by including six cases (12 graft limbs) performed because of nonocclusive disease (aneurysm or failure of graft performed for aneurysm). Excluding these, axillobifemoral primary and secondary patency decreased to 47% and 69%, respectively. Femorofemoral bypass results were made worse by cases performed because of unilateral failure of an aortic bifurcation graft. Exclusion of these bypasses increased primary and secondary patency rates to 74% and 82%, respectively. Occlusion of the major outflow artery (superficial femoral) markedly affected long-term patency of all three bypasses. Thus, "good" and "poor" runoff primary patencies were, respectively, for femorofemoral bypass 79% and 53%, for axillobifemoral bypass 92% and 41%, respectively (occlusive disease only), and for axillounifemoral bypass 54% and zero, respectively. This detailed breakdown of results explains the wide variances in the reported results for these extra-anatomic bypasses and provides a better perspective for their application in different clinical settings. (J VAsc SURG 1987;6:437-46.) 
The term "extra-anatomic bypass" implies deliberate avoidance of the natural anatomic pathway. The most common examples of extra-anatomic bypass are axiUofemoral and femorofemoral bypasses and their combination, the so-called axillobifemoral bypass; in these procedures, abdominal entrance is deliberately avoided. The two categorical reasons for doing this are (1) to avoid "hostile" intra-abdominal pathologic features and (2) to avoid the higher risk of transabdominal reconstruction in patients with serious visceral or systemic disease. In the former instance, there may be no reasonable alternative; in the latter, one is accepting a lesser degree and duration of benefit in exchange for lower mortality and morbidity rates. Mortality and patency rates are the traditional measures of risk and benefit, respectively, and yet the literature reveals fourfold differences in operative mortality rate and a twofold difference in long-term patency for each of the three extra-anatomic bypasses (Table I) . In this report, a 15-year experience with these extra-anatomic bypasses is analyzed according to selection and outcome variables. This analysis un- derscores the reasons for the wide variances in reported results and provides a better perspective of the resuks that can be expected when applying these bypasses in different clinical settings.
MATERIAL AND METHODS
The case records, arteriograms, and all available vascular laboratory data of patients undergoing either axiUounifemoral, axillobifemoral, or femorofemoral bypass during the period from 1971 to 1985, at either the University or Veterans Administration Hospitals in Denver, were analyzed in terms of indica-437 438 
OBSERVATIONS
Sixty femorofemoral, 15 axillounifemoral, and 27 axiUobifemoral bypasses were performed in 102 patients (129 graft limbs). The primary reasons behind the choice of each of these three extra-anatomic bypasses are categorically summarized in Table II . Three axillounifemoral bypasses were performed because of graft infection and four because of occlu-sion(s) of previous transabdominal reconstructions. In the remaining eight bypasses, there were no contraindications to a transabdominal repair other than poor anesthetic risk. All patients were facing amputation and all but one (aged 84 years) had a significant organ-specific risk factor.
Two of 27 patients undergoing axillobifemoral bypass had occlusion of a previous aortoiliac reconstruction; one additional patient had an aortoenteric fistula and three others had abdominal pathologic conditions (malignancy in two and vena caval or renal vein anomalies in one). In the remaining 21 patients, the choice of axillobifemoral bypass was made solely on the basis of presumed poor anesthetic risk. Age alone (82 to 91 years) was the determining factor in five of these patients and four of these procedures were performed for bypass and exclusion of abdominal aortic aneurysm. In the remainder, significant organ-specific risk factors were cited, the most common of which was chronic obstructive pulmonary disease. Except for five patients (two with failed previous reconstructions), all those undergoing elective reconstruction for chronic ischemia faced amputation.
In contrast, femorofemoral bypass was carried out because of claudication in most cases (55%). In 13 cases (21.6%) this was performed after unilateral graft limb failure of a previous aortic bifurcation graft; however, although an additional 25 (41.6%) could be categorized as "poor risk," the remaining 22 (36.6%) were neither poor-risk patients nor had a previous graft failure nor "hostile" abdominal Volume 6 Number 5 November 1987 Extra-anatomic b~ass 439 pathologic conditions to deter a transabdomina] reconstruction. In these cases, femorofemoral bypass was clearly performed as a matter of preference. Table III compares the operative mortality, early occlusion, and initial hemodynamic failure rates for each of these grafts. There were no operative deaths associated with femorofemoral bypass, compared with 11% and 13% for axillounifemoral and axillobifemoral bypass, respectively. There were three graft limb failures within 30 days after axillobifemoral bypass and two after femorofemoral bypass. All but a femorofemoral limb of an axillobifemoral bypass were reoperated on with patency restored by thrombectomy. Hemodynamic failure, defined as failure to improve ankle-brachial index by at least 0.10 in the presence of open grafts, occurred most frequently after axillobifemoral bypass (13%). In the femorofemoral bypasses, this was due to the severity of distal disease (runoff) in every instance. However, in 60% of the other bypasses with hemodynamic failure, the thigh-brachial index did not improve either, suggesting an inflow problem. This involved the contralateral limb in three of the axillobifemoral bypasses. Table IV compares the femorofemoral and the axiUofemoral bypasses in terms of severity of both the proximal (aortoiliac) disease and the distal (SFA) occlusive disease by examining the preoperative and postoperative thigh-brachial and ankle-brachial indexes. ~ SFA occlusion was present in 61% and 63%, respectively, of the axiUobifemoral and femorofemoral bypasses. The severity of their distal occlusive disease, as represented by the difference between the thigh-brachial and ankle-brachial indexes, were roughly equal. However, although the preoperative thigh-brachial indexes were also quite similar, suggesting equivalent degrees of proximal occlusive disease, the degree of improvement in both indexes was less in the axillobifemoral bypass group, suggesting that this lesser degree ofhemodynamic improvement is more related to inflow rather than outflow. Examination of individual data indicated this to be true *There were insufficient noninvasive data on the axillounifemoral grafts to make their inclusion in the comparison valid.
in four of seven graft limbs without significant improvement in the ankle-brachial index.
Tables V, VI, and VII provide the overall lifetable data and estimated patency rates at 3-month intervals up to 5 years for axillounifemoral, axillobifemoral, and femorofemoral bypasses, respectively. Finally, Table VIII summarizes the primary and secondary rates for each of these three bypasses. The overall results were further broken down according to rtmoffstatus (i.e., SFA patency or occlusion) and, in the case of the axillounifemoral or axiUobifemoral grafts, whether they were performed because of occlusive or nonocclusive disease (i.e., aneurysm or failure of graft performed to treat aneurysm) or in the case of the femorofemoral graft, whether it was performed to treat occlusive disease of the native iliac artery or failure of one limb of an aortic bifurcation graft.
The primary and secondary patency rates for the axillounifemoral bypass at 5 years are only 19% and 37%, respectively--clearly inferior to the other two bypasses. Although the overall 5-year patencies of axillobifemoral and femorofemoral bypasses are not significantly different from each other (62% vs. 67% primary patency and 81% vs. 74% secondary patency), the overall axillobifemoral patency rates benefit from the inclusion of cases performed to treat nonocclusive disease, all with good runoff and with primary and secondary patency rates at 5 years of 91% and 100%, respectively. Eliminating these and Volume 6 Number 5 November 1987 Extra-anatomic b~ass 441 1 and 2 , it can be seen that the femorofemoral bypass clearly has the best primary patency rate, but because of the more frequent use of thrombectomy and/or revision with axillobifemoral bypass, this advantage of femorofemoral bypass in secondary patency is not statistically significant. This view of the superiority of the femorofemoral bypass in patency is further enhanced if those patients who already had a failed proximal reconstruction, that is, the 13 cases in which the femorofemoral bypass was performed because of unilateral bifurcation graft limb failure, are eliminated from consideration. This subgroup had 5-year primary and secondary patency rates of only 39% and 51%, respectively. Thus, when performed as a primary procedure to treat occlusive disease of the native lilac artery, femorofemoral bypass carried primary and secondary 5-year patency rates of 74% and 82%, respectively. The contrasting results in these two subgroups are shown in Figs. 3 and 4. Runoff status, specifically the patency of the major outflow vessel, the SFA, significantly affected the long-term patency of each of these extra-anatomic bypasses, as shown in Figs. 5, 6, and 7 and Table VIII. The presence of SFA occlusion lowered the 5-year patency of the femorofemoral bypass from 79% to 53% primary patency and from 95% to 67% secondary patency. Occlusion of the SFA lowered the patency of the axillobifemoral bypass performed to treat occlusive disease from 92% (primary and secondary patency) to 41% primary and 58% secondary patency. Finally, axillounifemoral bypass with good runoff enjoyed a 54% primary and secondary patency compared to zero when performed in the face of SFA occlusion, with no such graft remaining open beyond 27 months.
DISCUSSION
Although the busy surgeon, faced with a voluminous literature on the results of vascular surgery, tends to focus on summarized data, such "bottomline" information may be misleading or lead to inconsistent conclusions. The literature on extraanatomic bypass has been particularly "guilty" in this regard because of major differences in case selection and patency criteria and the "lumping" together of overall results. The twofold differences in patency reported in the literature for each of these three extraanatomic bypasses are for the most part a reflection of whether the authors considered any graft that ever thrombosed as occluded in their patency projections s'4 or also counted grafts maintained open by thrombectomy or revision.S7 Only by reporting both primary and secondary patency rates, as done in this and one other report, 9 is the reader given a true perspective of the durability (or lack thereof) of these bypasses.
Our 0vera//results appear similar to some reports and at variance with others; however, with the exception of axillounifemoral bypass, which fared worse than in other reports, they can probably all be explained on the basis of case selection and use of primary vs. secondary patency. The "better" axillobifemoral results come from the inclusion of cases performed because of nonocclusive disease; the "good" femorofemoral results may come from the more frequent use of this bypass in daudicants with isolated iliac artery occlusive disease, although some other reports are not as clear on these details. However, rather than focusing on specific numeric end points, the general trends and the effect of certain clinical characteristics on these end points are the important considerations.
Clearly the results of these extra-anatomic bypasses should not be combined. Femorofemoral bypass gives vastly superior results in every aspect to axillounifemoral bypass; the combination of these two procedures, the axillobifemoral bypass, falls in an intermediate position. Furthermore, one should not consider together the results of axillobifemoral bypasses performed to treat nonocclusive disease with the results of those done to treat occlusive disease. Nor should one ignore the effect of including patients who have already had one failed proximal bypass with those in whom the bypass was the primary operation to treat aortoiliac occlusive disease.
The other major categorical contributor to the wide variance in results reported in the literature on extra-anatomic bypass (i.e., differences in case selection), is more difficult to gauge yet reflects variables that have a profound effect on outcome. For example, there was an almost fourfold difference in the mortality rate after axillobifemoral bypass in two reports emanating from the same institutions within a short Volume 6 Number 5 November 1987 Extra-anatomic bypass 443
L._. :..e: for iliac artery occlusive disease interval. The reason was the exclusion of emergent and urgent cases in one report. 6'7 A similar almost fourfold difference in mortality rate after femorofemoral bypass between reports from different institutions can be attributed to the tendency of one institution to reserve the operation, at that point in time, primarily for poor-risk patients facing amputation, 4 whereas in the other institution this bypass was performed as a matter of preference.i° Case selection also has a significant effect on longterm patency, primarily because of differences in runoff status associated with clinical status. Clearly, it is more likely for patients who face amputation to have multilevel occlusive disease and thus poor runoff. No other bypass is more adversely affected by poor runoff than these extra-anatomic bypasses. The striking effect of SFA occlusion on the patency of each of these grafts has been previously described 2's'6 and is a striking feature of this study. In fact, runoff status was the factor with the greatest single effect on patency (Table VIII) .
On the basis of our results, we do not believe that axillofemoral bypass, either unilateral or bilateral, should be performed on patients who have occlusive disease and whose indication for operation is claudication. On the other hand, femorofemoral by- pass seems justified for disabling claudication in patients who are reasonable risks with unilateral iliac artery occlusive disease and good runoff. Femorofemoral bypass can be considered the procedure of choice in this setting unless there is a discrete common iliac stenosis, for which balloon angioplasty offers equal results at less risk and cost. u By the same token, such a lesion on the contralateral side can be dilated to allow femorofemoral bypass to be performed rather than aortobifemoral bypass. ~2 Hemodynamic failure, gauged by failure to increase the ankle-brachial index by at least 0.10, is usually a reflection of poor runoff and, indeed, in all cases reported herein, the SFA was occluded. How-ever, the failure rate was higher for axiUobifemoral (13%) than femorofemoral (7%)bypass despite equivalent severity of proximal and distal occlusive disease. Whether the higher hemodynamic failure rate with the axillobifemoral bypass is related to the relatively smaller "donor" artery or the longer, smaUdiameter graft, or both, cannot be determined from our data, but it does suggest that these inflow factors may make a more important hemodynamic contribution than previously claimed, is In this regard, we have observed two patients with axillobifemoral bypasses who had normal runoff and normal resting ankle-brachial indexes who complained of claudication and had a marked decrease in ankle pressure with It is still debatable whether one should perform axillobifemoral bypass rather than axillounifemoral bypass when dealing with only a unilateral ischemic limb threat. The theoretic basis for the axillobifemoral bypass is that the additional graft limb, presuming it bypasses significant contralateral iliac artery occlusive disease, will significantly increase the flow through the axillofemoral graft and thus significantly increase its patency; this is because each extremity placed in parallel circuit beyond the donor artery reduces the resistance in, and increases the distribution of cardiac output to, that artery. This theory appears to have been confirmed by the observation LoGerfo et al. 6 that axillobifemoral bypass had twice the flow in the axillofemoral limb and twice the pa-teneT rate compared with axiUounifemoral bypass. However, two other series have shown no statistically significant difference in patency in favor of the axillobifemoral over the axillounifemoral bypass 4'9 and only one other series has also shown moderately better pateneT for axillobifemoral bypasses, s Our series adds weight to the claim by LoGerfo et al. by showing significantly better primary and secondary patene T rates for axillobifemoral over axillounifemoral bypass not only for overall data but when categorized according to good and poor runoff. Therefore, we believe that axillobifemoral bypass should be performed in preference to axillounifemoral bypass if there is also iliac occlusive disease on the contralateral side, even if the other limb does not have symptoms serious enough to justify operation alone.
We have been conservative in our application of History of multiple previous operations with adhesions, extensive irradiation, retroperitoneal fibrosis Malignancy Unresectable primary or metastatic lesions the two axillofemoral bypasses in contrast to our rather liberal use of the femorofemoral bypass. By generally withholding the axillofemoral bypasses for limb salvage indications and categorically poor-risk patients (except for an occasional patient with graft sepsis or aortoenteric fistula), we realize we are probably adversely affecting our results and ending up with a higher mortality rate and lower long-term pateneT rates than those who apply this operation more liberally. Furthermore, by excluding the greatest risk patients from transabdominal reconstruction, one tends to improve the results of aortobifemoral bypass and can end up having a paradoxically higher 446 Rutherford, Pat:t,  
and Pearce
Journal of VASCULAR SURGERY operative mortality rate for the lower risk subcutaneous bypass. 4 ' 14 In applying axillobifemoral bypass in lieu of aortobifemoral bypass, there is essentially a "trade-off' between operative mortality rates and long-term patency that can only be optimized with careful patient selection. Because technologic advancements in perioperative monitoring and intensive care have significantly reduced the risk of aortobifemoral bypass, we believe we should not accept the clearly inferior results of axillobifemoral bypass in patients being operated on electively for occlusive disease unless the nature of their intra-abdominal pathologic condition or anesthetic risk is truly prohibitive, such as those outlined in Table IX . The higher risk of hemodynamic failure and the need for thrombectomy and revision to preserve the patency of the axiUobifemoral bypass adds further weight to this conservative attitude. On the other hand, one should not use the poor result of axillobifemoral bypass when performed for occlusive disease in the face of poor runoff to justify not using it in patients with graft sepsis, aortoenteric fistulas, and even high-risk patients with aortic aneurysms that might be treated by inflow or outflow occlusion. Since one is not dealing with occlusive disease and most of these cases have good runoff, the results are quite good and may be far preferable to the risks of in situ reconstruction.
